Amanote Research
Register
Sign In
Time on Therapy for at Least Three Months Correlates With Overall Survival in Metastatic Renal Cell Carcinoma
Cancers
- Switzerland
doi 10.3390/cancers11071000
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
July 17, 2019
Authors
Unknown
Publisher
MDPI AG